openPR Logo
Press release

Primary Care Doctor Market is Propelled by Rising Aging Population and Increasing Prevalence of Chronic Health Conditions

05-23-2017 03:53 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Primary Care Doctor Market is Propelled by Rising Aging

Primary care doctors are the licensed healthcare professionals who diagnose and treat individuals, and help them in restoring their health condition, and thus bring them back to the active life through reducing the physiological complications and restoring the body functions. They are the primary point of advice for the patients due to a number of factors like easy communication, familiarity and the need of cost management. They may refer the patients to a specialized care for the further treatment process. They prescribe a particular diagnosis for the patient and interpret results from it, and thus they formulate a plan, a medication, therapy, referral to specialist and follow-up the results of treatment. Primary care doctors are present in hospitals, private practices, outpatient clinics, home health agencies, and nursing homes. The activities by the doctors in the industry includes examining the patient’s history, designing the technique or management plan, incorporating the results and providing therapy and education.

Browse through Primary Care Doctor Market report to know what factors will shape the market by 2023: http://www.transparencymarketresearch.com/primary-care-doctor-market.html

Based on various types of treatment, the Primary care market can be segmented as follows:

Family Medicine Doctors: They are board certified to check-up people of all ages.
Internal Medicine Doctors: They check-up people above 14 years of age. They check internal organs of the body and prescribes medicine for it. Some of them can also provide care for gynecology and dermatology.
Gynecologist or Obstetrician: These physicians provide special care to the women during and after the reproductive phase. Almost all Gynecologists have specialty in Obstetrics.
Geriatricians: These physicians have special education to treat adults over 60. They provide medication management and mental assessment related falls and other aging issues.
Pediatricians: There are certified to diagnose and treat children from newborn through age 21, through a wide range of diseases.

Some of the major driving factors for the market growth include rising aging population and increasing prevalence of chronic health conditions. Due to the federal healthcare reform, there is high rate of private insurance which made the private healthcare services much affordable for the U.S. population.

Get accurate market forecast and analysis on the Primary Care Doctor Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6916

Geographically, the Primary care doctors market can be segmented into six major regions: North America, Europe, Asia Pacific, Latin America, Middle East and Rest of the World (RoW). North America holds the leading position in the Primary care doctors market followed by Europe. Stronger primary care would be an important policy goal by the Senate Finance Committee and House Ways and Means Committee in U.S. because primary care practices that have been redesigned to ensure the provision of patient-centered, coordinated care is a key of high-performance health system. Key factors responsible for their dominance in this market are high aging population, increasing active lifestyle of people, high healthcare expenditure by the government, reimbursement policy and the presence of huge number of physicians. In 2015, there are around 176,893 primary care doctors in Internal Medicine licensed in the U.S. Asia Pacific is the most promising market for the growth of Primary care doctors market due to various emerging economies. Although there are many challenges for primary care physicians like misdistribution and decreasing quality of care measures, key factors contributing towards the growth of the market in these regions include easy market penetration, favorable reimbursement scenario, cheap medication and development of various healthcare infrastructures such as hospitals, clinics, etc.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Primary Care Doctor Market is Propelled by Rising Aging Population and Increasing Prevalence of Chronic Health Conditions here

News-ID: 547674 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Primary

Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Global Primary Sclerosing Cholangitis Market
The Primary Sclerosing Cholangitis report offers insights into vital aspects like growth,CAGR value, market share and revenue analysis. It evaluates the growth opportunities, threats, market drivers and risks involved. understand the market competition by analyzing the top vendors, with their market profile, revenue, profits, import-export details, and market share. it states the pricing structure, import-export details, supply chain analysis, SWOT analysis to facilitate the key decision-making process. This report helps
Primary Lithium Battery (Primary Lithium Batteries) Industry Analysis by 2025:  …
In its recently published report, QY Research has provided unique insights about global Primary Lithium Battery (Primary Lithium Batteries) market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments of the global Primary
Primary Cells And Primary Batteries Market Analysis by Production Capacity, Dyna …
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Primary Cells And Primary Batteries market. Description The Global Primary Cells And Primary Batteries Market report offers a comprehensive evaluation of the Global Primary Cells And Primary Batteries industry. This report evaluates the Global market for " Global Primary Cells And Primary Batteries". The Global Primary Cells
Primary Immunodeficiency Diseases Market: Key Insights
With only a handful of companies enjoying the major share of the revenue pie, the global primary immunodeficiency diseases (PIDD) market exhibits a consolidated vendor landscape. As per Transparency Market Research (TMR), CSL Behring LLC and Grifols S.A. emerged dominant in the market with a share of 60.5% in 2014. Baxter International, Inc. and Octapharma AG are other prominent enterprises operating in the global PIDD market. These companies have been
01-25-2017 | Health & Medicine
TMR
Global Primary Biliary Cholangitis Treatment Market is Driven by Rise in Inciden …
Primary biliary cholangitis, previously known as primary biliary cirrhosis, is a rare chronic liver disease, primarily characterized by destruction of the bile ducts which transport bile acid out of the liver. Although the primary cause of the disease has not yet been elucidated, research across the world has attributed it to be autoimmune in nature. The progress of this disease results in the harmful accumulation of bile acid, which causes